Skip to main
MPLT

MPLT P/E Ratio

P/E Ratio as of Apr 8, 2026: -6.53

Average-5.51
Median-5.47
Minimum-6.53
Maximum-4.57
-6.53
The P/E ratio for MPLT is -6.53 as of Apr 8, 2026. This represents a increase of 668.24% compared to its 12-month average P/E ratio of -0.85. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

MapLight Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

MapLight Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing MapLight Therapeutics Inc to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

MPLT P/E Ratio Historic Data

DateStock priceP/E ratio

MPLT End of Year P/E Ratio

DateP/E ratioChange
2026-6.53

FAQs About MapLight Therapeutics Inc (MPLT) P/E ratio

The latest P/E ratio of MPLT is -6.53, as of Apr 8, 2026. This is calculated based on its current stock price and earnings per share (EPS).

MapLight Therapeutics Inc’s last 12-month average P/E ratio is -0.85, compared to its current P/E ratio of -6.53. This reflects a increase of 668.24%.

MapLight Therapeutics Inc’s current P/E ratio of -6.53 is higher than its last 12-month average P/E of -0.85. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

MapLight Therapeutics Inc’s average P/E ratio over the last 3 years is -0.28. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

MapLight Therapeutics Inc’s average P/E ratio over the last 5 years is -0.17. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

MapLight Therapeutics Inc (MPLT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.